Sequential IgE-epitopes of ovomucoid exposed by glutathione are relevant in persistent egg allergy
© Kinaciyan et al; licensee BioMed Central Ltd. 2013
Published: 25 July 2013
The egg allergen ovomucoid (Gal d 1) is conformationally stabilized by 9 disulfide bonds. However, patients with persistent egg-allergy have more IgE against sequential than conformational epitopes of ovomucoid. We investigated whether natural or added food compounds may cause reduction of disulfide bonds and linearization of ovomucoid.
Reduced ovomucoid in raw eggwhite was detected using a fluorescence-labeled alkylation probe. The common anti-oxidants glutathione and cystein were used for in vitro linearization and effects were monitored by CD-spectrometry. Egg-allergic patients were tested serologically (n=19) and by skin prick test (n=9) for IgE against native and linearized ovomucoid and optionally its cooked state.
Linearized ovomucoid could be detected in native eggwhite. Glutathione and cystein treatments, but not cooking linearized ovomucoid, as confirmed by CD-spectrometry. In Western Blot involving cooking more patients had IgE against reduced than native ovomucoid. In ELISA, most IgE was found against raw and native ovomucoid. Cooking of native ovomucoid significantly decreased, whereas cooking of previously linearized ovomucoid enhanced IgE-binding. In skin prick test 5/9 patients reacted with linearized ovomucoid.
Linearized ovomucoid is present in natural eggwhite. Glutathione which is occurring naturally but is also frequently used as structure improving additive in processed food is partly responsible. Additional cooking of linearized ovomucoid increases IgE-reactivity in patients with persistent egg-allergy in vitro and in skin prick tests. Our data provide evidence that reduction is a novel principle which contributes to the allergenicity of food. This may be relevant for new allergies to modern processed food.
Disclosure of interest
The work was supported by L467-B05, SFB F1808-B13, SFB 4606-B19 and CCHD APW01205FW of the FWF, Austrian Science Fund.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.